Company profile
ENvue Medical, Inc.
NASDAQ: FEED · Healthcare · Medical - Specialties
#770 of 1,418 Healthcare companies by revenue41st-percentile growth
EA Score
46DFH 46DQ 47GM 53SS 24
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, 3-yr revenue growth · ↓ listing tenure, filing timeliness
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-17.7%
Net income (FY)
-$18.2M
Employees
13
as of 2026-08-26
Market cap
$3.6M
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.6M$2.6M2025
Net income-$18.2M-$18.2M2025
Operating income-$22.9M-$22.9M2025
Total assets$41.1M$41.1M2025
Liabilities$7.6M$7.6M2025
Equity$33.5M$33.5M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ENvue Medical, Inc.’s revenue?
ENvue Medical, Inc. booked $2.6M in FY2025 revenue, contracting 0.2% year over year — about the middle of the pack among Healthcare companies we track, at a -712.3% net margin.
Peers · Healthcare
QHSLab, Inc.70BInnovative Eyewear, Inc.44DInfinity Pharmaceuticals, Inc.——Fiore Cannabis Ltd.——GeoVax Labs, Inc.38DWayland Group Corp.——Neighbors
Cook →Key facts
CEODoron Robert Besser
SectorHealthcare
IndustryMedical - Specialties
HeadquartersArlington Heights, IL
ExchangeNASDAQ: FEED
Employees13
IPO date2025-12-12
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.